Health-related quality of life and psychological distress among the elderly with polypharmacy in elderly care homes of urban-Sri Lanka

Abstract Background Population ageing has led to a growing prevalence of multimorbidity and polypharmacy, especially among institutionalized older adults. Polypharmacy, commonly defined as the concurrent use of five or more medications, poses significant risks, including adverse drug reactions, poor adherence, cognitive decline, and reduced quality of life. Despite global evidence linking polypharmacy with diminished health-related quality of life (HRQOL) and heightened psychological distress, Sri Lanka lacks research examining this relationship within elderly care homes, a population uniquely vulnerable due to chronic illness, social isolation and dependence on caregivers. This study aims to assess health related quality of life and psychological distress among elderly residents with polypharmacy in selected elderly care homes in the Colombo District, Sri Lanka, exploring the relationships between polypharmacy and these outcomes, and associations of these outcomes with key sociodemographic factors. Methods A descriptive cross-sectional study was conducted among elderly residents (≥ 60 years) experiencing polypharmacy across 10 registered elderly care homes. A stratified random sample of 201 participants proportionately from each care home was selected. Data was collected through interviewer-administered questionnaires using validated tools: WHOQOL-BREF for health-related quality of life and Depression Anxiety Stress Scale–21 (DASS-21) for psychological distress. Medication data were extracted via a structured checklist. Non-parametric tests, including Chi-square and Spearman correlation, and multiple linear regression were used for analysis. Results Most participants (96.5%) reported moderate HRQOL, while 82.1% demonstrated at least mild depressive symptoms, and 64.7% reported anxiety symptoms. Polypharmacy showed a significant negative association with HRQOL (χ² = 7.24, p = 0.027; ρ = − 0.449, p < 0.001) and significantly predicted poor HRQOL (β = − 0.41, p < 0.001). A strong positive association was observed between polypharmacy and psychological distress (χ² = 85.03, p < 0.001; ρ = 0.785, p < 0.001), with regression showing polypharmacy predicting higher distress levels (β = 0.78, p < 0.001). Conclusion High polypharmacy is significantly associated with reduced HRQOL and heightened psychological distress among institutionalized elderly in the Colombo district, Sri Lanka. These findings underscore the need for routine medication reviews, deprescribing strategies and enhanced psychological support that are essential to improve the well-being in this medically and socially vulnerable population.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-10545958/v1
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Health-related quality of life and psychological distress among the elderly with polypharmacy in elderly care homes of urban-Sri Lanka

P L P A Madhushyani, W G D Dishara, D S Jayawickrama, T M Arachchi et al.
4 links
Research Square
Pharmaceutical Practices and Patient Outcomes
preprint

Health-related quality of life and psychological distress among the elderly with polypharmacy in elderly care homes of urban-Sri Lanka

P L P A Madhushyani, W G D Dishara, D S Jayawickrama, T M Arachchi, M D Ruwanpathirana, G Y C Wickramanayake, G G N Sihara, D A S Elvitigala, U I Amarasiriwardhana, H K C L Perera
preprint en

Abstract

Abstract Background Population ageing has led to a growing prevalence of multimorbidity and polypharmacy, especially among institutionalized older adults. Polypharmacy, commonly defined as the concurrent use of five or more medications, poses significant risks, including adverse drug reactions, poor adherence, cognitive decline, and reduced quality of life. Despite global evidence linking polypharmacy with diminished health-related quality of life (HRQOL) and heightened psychological distress, Sri Lanka lacks research examining this relationship within elderly care homes, a population uniquely vulnerable due to chronic illness, social isolation and dependence on caregivers. This study aims to assess health related quality of life and psychological distress among elderly residents with polypharmacy in selected elderly care homes in the Colombo District, Sri Lanka, exploring the relationships between polypharmacy and these outcomes, and associations of these outcomes with key sociodemographic factors. Methods A descriptive cross-sectional study was conducted among elderly residents (≥ 60 years) experiencing polypharmacy across 10 registered elderly care homes. A stratified random sample of 201 participants proportionately from each care home was selected. Data was collected through interviewer-administered questionnaires using validated tools: WHOQOL-BREF for health-related quality of life and Depression Anxiety Stress Scale–21 (DASS-21) for psychological distress. Medication data were extracted via a structured checklist. Non-parametric tests, including Chi-square and Spearman correlation, and multiple linear regression were used for analysis. Results Most participants (96.5%) reported moderate HRQOL, while 82.1% demonstrated at least mild depressive symptoms, and 64.7% reported anxiety symptoms. Polypharmacy showed a significant negative association with HRQOL (χ² = 7.24, p = 0.027; ρ = − 0.449, p < 0.001) and significantly predicted poor HRQOL (β = − 0.41, p < 0.001). A strong positive association was observed between polypharmacy and psychological distress (χ² = 85.03, p < 0.001; ρ = 0.785, p < 0.001), with regression showing polypharmacy predicting higher distress levels (β = 0.78, p < 0.001). Conclusion High polypharmacy is significantly associated with reduced HRQOL and heightened psychological distress among institutionalized elderly in the Colombo district, Sri Lanka. These findings underscore the need for routine medication reviews, deprescribing strategies and enhanced psychological support that are essential to improve the well-being in this medically and socially vulnerable population.

Research Square
University of Colombo (LK)
Good health and well-being
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon